Alendronate

Alendronate

Alendronate sodium or Alendronic acid are the chemical names for the product Fosomax, marketed by Merck for the treatment of osteoporosis and other bone conditions. Fosomax can be sold alone or in combination with a vitamin D supplement. Merck’s patent on the drug expired in 2008, so Alendronate can now be purchased in generic form. It is currently the most widely prescribed drug of its type in America.

Alendronate has been tied to a number of adverse health conditions, including:

  • Osteonecrosis of the jaw, a deterioration of bone mass in the jaw, often associated with the incidence of any dental work
  • Esophageal cancer
  • Ulceration or tearing in the esophagus
  • Skin rash
  • Generalized muscle, bone and joint pain

If you or someone you love has suffered injury after being prescribed Alendronate or Alendronic acid, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.

Connect with Top-rated Attorneys Near You

    Latest Article

    Videos

        GETLEGAL®ATTORNEY DIRECTORY

        Find Leading Attorneys in Your Area

            NEED PROFESSIONAL HELP?

            Talk to an Attorney

            How It Works

            • Briefly tell us about your case
            • Provide your contact information
            • Choose attorneys to contact you

            About GetLegal

            Our mission at GetLegal is to develop a family of sites that constitute the most useful, informative, reliable and exciting collection of legal resources on the web. We are constantly working to expand and improve many resources we offer to legal professionals and the public.

            List Your Law Firm in the GetLegal Attorney Directory
            Advertise With Us
            Newsletter Sign-Up

            By submitting information to this site, you give permission to GetLegal, or a partner of GetLegal, to contact you by email.

            © 2008-2022 LawConnect, Inc. All rights reserved. Sitemap | Copyright/DMCA Policy | Privacy Policy | Terms of Use | Disclosures/Disclaimers